{"id":"W2793831611","doi":"10.1002/cncr.31304","title":"Efficacy and safety results of depatuxizumab mafodotin (ABT‐414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor","year":2018,"lang":"en","type":"article","venue":"Cancer","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"AbbVie","keywords":"Medicine; Epidermal growth factor receptor; Epidermal growth factor; Solid tumor; Internal medicine; Cancer research; Oncology; Human Epidermal Growth Factor Receptor 2; Receptor; Pharmacology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008655137,0.000592593,0.0007745333,0.0002448126,0.0002434161,0.0004222108,0.0002927777,0.0005324107,0.001016369],"category_scores_gemma":[0.0008071709,0.0002226699,0.000779979,0.0002342921,0.0004094094,0.0004083484,0.0001518902,0.001080951,0.0002683168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006260352,"about_ca_system_score_gemma":0.000404852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004985031,"about_ca_topic_score_gemma":0.0005497707,"domain_scores_codex":[0.9997486,0.0001105603,0.00001960808,0.00004143832,0.00003808132,0.00004157687],"domain_scores_gemma":[0.9994022,0.000164484,0.0001665456,0.00003529682,0.00004341011,0.0001881329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.432191,0.03333137,0.1084027,0.0009900985,0.001693986,0.002052007,0.000830019,0.00922705,0.1653309,0.0002623512,0.004083044,0.2416054],"study_design_scores_gemma":[0.07315381,0.7101428,0.1810629,0.00005737259,0.001096271,0.002608381,0.0001250034,0.003989248,0.02259626,0.0001843323,0.00493285,0.00005077218],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977323,0.001202404,0.0001613768,0.00009417643,0.00001555264,0.00009885101,0.0001970657,0.00001565059,0.0004825168],"genre_scores_gemma":[0.9979535,0.0005644147,0.0003103933,0.0001326073,0.000048804,0.00007973042,0.0005443416,0.000005971558,0.000360169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001016369,"threshold_uncertainty_score":0.004577339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009701893295899596,"score_gpt":0.2861562730790419,"score_spread":0.2764543797831423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}